Sensus Healthcare to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

Sensus Healthcare (Nasdaq: SRTS), based in Boca Raton, Fla., will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference, held virtually from September 13 to 15, 2021. CEO Joe Sardano's presentation will be accessible via a webcast starting at 7:00 am (EST) on September 13. Sensus Healthcare specializes in non-invasive treatments for both oncological and non-oncological conditions, featuring technologies like the Sculptura™ and SRT-100™ systems, aimed at enhancing patient quality of life.

Boca Raton, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced that Joe Sardano, chairman and chief executive officer, will present at the H.C. Wainwright 23^rd Annual Global Investment Conference to be held virtually from September 13 – 15, 2021.

A webcast of the virtual presentation will be available starting at 7:00 am (EST) on Monday, September 13, 2021, and can be accessed through the Investors Relations section of Sensus Healthcare’s website at www.sensushealthcare.com or directly through the webcast link. An archived replay of the webcast will be available on the Company’s website after the conference.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted directional anisotropic radiation therapy (ART) and brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit www.sensushealthcare.com.

Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com

FAQ

When is the H.C. Wainwright 23rd Annual Global Investment Conference for Sensus Healthcare (SRTS)?

The conference will be held virtually from September 13 to 15, 2021.

Who is presenting for Sensus Healthcare at the investment conference?

Joe Sardano, the CEO and chairman, will present at the conference.

What time will Sensus Healthcare's presentation start during the conference?

The presentation will begin at 7:00 am (EST) on September 13, 2021.

How can I access the webcast for Sensus Healthcare's presentation?

The webcast can be accessed through the Investors Relations section of Sensus Healthcare's website.

What technologies does Sensus Healthcare (SRTS) specialize in?

Sensus Healthcare specializes in non-invasive treatments, including the Sculptura™ and SRT-100™ systems for oncological and non-oncological conditions.